Defining order and timing of mutations during cancer progression: The TO-DAG probabilistic graphical model

Frontiers in Genetics

Volumn 6, Issue OCT, 2015, Pages

  Lecca, Paola ^a   Casiraghi, Nicola ^a   Demichelis, Francesca ^a,b  

^a UNIVERSITY OF TRENTO   (Italy)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cumulative cancer progression models; Graph inference; Melanoma; Mutagenetic graphs; Prostate cancer; Timed graphs

Indexed keywords

ARTICLE; CANCER GROWTH; HUMAN; INFORMATION PROCESSING; MELANOMA; MUTATION RATE; PHENOTYPE; PROSTATE CANCER; SAMPLE SIZE; STATISTICAL DISTRIBUTION; TIMED ONCOGENETIC DIRECTED ACYCLICGRAPH; TUMOR SUPPRESSOR GENE;

EID: 84947078703     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2015.00309     Document Type: Article

References (39)

1. Alizadeh, A. A., Aranda, V., Bardelli, A., Blanpain, C., Bock, C., Borowski, C., et al. (2015). Toward understanding and exploiting tumor heterogeneity. Nat. Med. 21, 846-853. doi: 10.1038/nm.3915
2. Attolini, C. S., Cheng, Y. K., Beroukhim, R., Getz, G., Abdel-Wahab, O., Levine, R. L., et al. (2010). A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc. Natl. Acad. Sci. U.S.A. 107, 17604-17609. doi: 10.1073/pnas.1009117107
3. Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., et al. (2013). Punctuated evolution of prostate cancer genomes. Cell 153, 666-677. doi: 10.1016/j.cell.2013.03.021
4. Barbieri, C. E., Baca, S. C., Lawrence, M. S., Demichelis, F., Blattner, M., Theurillat, J.-P., et al. (2012). Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 1-7. doi: 10.1038/ng2279
5. Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzler, K. W., Velculescu, V. E., et al. (2007a). Genetic progression and the waiting time to cancer. PLoS Comput. Biol. 3:e225. doi: 10.1371/journal.pcbi.0030225
6. Beerenwinkel, N., Eriksson, N., and Sturmfels, B. (2007b). Conjunctive Bayesian networks. Bernoulli 13, 893-909. doi: 10.3150/07-BEJ6133
7. Beerenwinkel, N., Rahnenführer, J., Kaiser, R., Hoffmann, D., Selbig, J., and Lengauer, T. (2005). Mtreemix: a software package for learning and using mixture models of mutagenetic trees. Bioinformatics 21, 2106-2107. doi: 10.1093/bioinformatics/bti274
8. Beltran, H., and Demichelis, F. (2015). Prostate cancer: intrapatient heterogeneity in prostate cancer. Nat. Rev. Urol. 12, 430-431. doi: 10.1038/nrurol.2015.182
9. Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., et al. (2012). Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485, 502-506.
10. Breitung, K. (1989). Ripley, B. D. Stochastic simulation. Stat. Pap. 30, 184-184.
11. Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., et al. (2012). Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413-421. doi: 10.1038/nbt.2203
12. Cheng, Y. K., Beroukhim, R., Levine, R. L., Mellinghoff, I. K., Holland, E. C., and Michor, F. (2012). A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis. PLoS Comput. Biol. 8:e1002337. doi: 10.1371/journal.pcbi.1002337
13. Desper, R., Jiang, F., Kallioniemi, O. P., Moch, H., Papadimitriou, C. H., and Schäffer, A. A. (2000). Distance-based reconstruction of tree models for oncogenesis. J. Comput. Biol. 7, 789-803. doi: 10.1089/10665270050514936
14. Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., et al. (2004). A census of human cancer genes. Nat. Rev. Cancer 4, 177-183. doi: 10.1038/nrc1299
15. Garraway, L. A., and Lander, E. S. (2013). Lessons from the cancer genome. Cell 153, 17-37. doi: 10.1056/NEJMoa1113205
16. Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., et al. (2012). Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892.
17. Gerstung, M., Baudis, M., Moch, H., and Beerenwinkel, N. (2009). Quantifying cancer progression with conjunctive Bayesian networks. Bioinformatics 25, 2809-2815. doi: 10.1093/bioinformatics/btp505
18. Gerstung, M., Eriksson, N., Lin, J., Vogelstein, B., and Beerenwinkel, N. (2011). The temporal order of genetic and pathway alterations in tumorigenesis. PLoS ONE 6:e27136. doi: 10.1371/journal.pone.0027136
19. Greaves, M., and Maley, C. C. (2012). Clonal evolution in cancer. Nature 481, 306-313. doi: 10.1038/nature10762
20. Hainke, K., Rahnenführer, J., and Fried, R. (2012). Cumulative disease progression models for cross-sectional data: a review and comparison. Biom. J. 54, 617-640. doi: 10.1002/bimj.201100186
21. Hjelm, M., Höglund, M., and Lagergren, J. (2006). New probabilistic network models and algorithms for oncogenesis. J. Comput. Biol. 13, 853-865. doi: 10.1089/cmb.2006.13.853
22. Johnsonbaugh, R., and Kalin, M. (1991). A graph generation software package. SIGCSE Bull. 23, 151-154.
23. Kinzler, K. W., and Vogelstein, B. (1997). Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386, 761, 763.
24. Longerich, T., Mueller, M. M., Breuhahn, K., Schirmacher, P., Benner, A., and Heiss, C. (2012). Oncogenetic tree modeling of human hepatocarcinogenesis. Int. J. Cancer 130, 575-583. doi: 10.1002/ijc.26063
25. Merlo, L. M., Pepper, J. W., Reid, B. J., and Maley, C. C. (2006). Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924-935. doi: 10.1038/nrc2013
26. Michor, F., Iwasa, Y., and Nowak, M. A. (2004). Dynamics of cancer progression. Nat. Rev. Cancer 4, 197-205. doi: 10.1038/nrc1295
27. Perner, S., Mosquera, J. M., Demichelis, F., Hofer, M. D., Paris, P. L., Simko, J., et al. (2007). TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am. J. Surg. Pathol. 31, 882-888. doi: 10.1097/01.pas.0000213424.38503.aa
28. Prandi, D., Baca, S. C., Romanel, A., Barbieri, C. E., Mosquera, J. M., Fontugne, J., et al. (2014). Unraveling the clonal hierarchy of somatic genomic aberrations. Genome Biol. 15, 439. doi: 10.1186/s13059-014-0439-6
29. Radmacher, M. D., Simon, R., Desper, R., Taetle, R., Schäffer, A. A., and Nelson, M. A. (2001). Graph models of oncogenesis with an application to melanoma. J. Theor. Biol. 212, 535-548. doi: 10.1006/jtbi.2001.2395
30. Rahnenführer, J., Beerenwinkel, N., Schulz, W. A., Hartmann, C., von Deimling, A., Wullich, B., et al. (2005). Estimating cancer survival and clinical outcome based on genetic tumor progression scores. Bioinformatics 21, 2438-2446. doi: 10.1093/bioinformatics/bti312
31. Sakoparnig, T., and Beerenwinkel, N. (2012). Efficient sampling for Bayesian inference of conjunctive Bayesian networks. Bioinformatics 28, 2318-2324. doi: 10.1093/bioinformatics/bts433
32. Schaefer, G., Mosquera, J. M., Ramoner, R., Park, K., Romanel, A., Steiner, E., et al. (2013). Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. Prostate Cancer Prostatic Dis. 16, 132-138. doi: 10.1038/pcan.2013.4
33. Stratton, M. R., Campbell, P. J., and Futreal, P. A. (2009). The cancer genome. Nature 458, 719-724. doi: 10.1038/nature07943
34. Sun, S., Klebaner, F., and Tian, T. (2014). A new model of time scheme for progression of colorectal cancer. BMC Syst. Biol. 8(Suppl. 3): S2. doi: 10.1186/1752-0509-8-S3-S2
35. Szabo, A., and Boucher, K. (2002). Estimating an oncogenetic tree when false negative and positives are present. Mathematical Biosciences 176, 219-236. doi: 10.1016/S0025-5564(02)00086-X
36. Turajlic, S., McGranahan, N., and Swanton, C. (2015). Inferring mutational timing and reconstructing tumour evolutionary histories. Biochim. Biophys. Acta 1855, 264-275. doi: 10.1016/j.bbcan.2015.03.005
37. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., et al. (1988). Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525-532. doi: 10.1056/NEJM198809013190901
38. Weinstein, I. B., and Joe, A. (2008). Oncogene addiction. Cancer Res. 68, 3077-3080; discussion 3080. doi: 10.1158/0008-5472.CAN-07-3293
39. Weischenfeldt, J., Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, S., et al. (2013). Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 23, 159-170. doi: 10.1016/j.ccr.2013.01.002